Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma

by Mark J. de Lange, Rogier J. Nell, Pieter A. van der Velden
Published 2021-08-01

Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma

by Rogier J. Nell, Nino V. Menger, Mieke Versluis, Gregorius P. M. Luyten, Robert M. Verdijk, Michele C. Madigan, Martine J. Jager, Pieter A. van der Velden
Published 2021-02-01

In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target

by Anna M.W. ten Voorde, Annemijn P.A. Wierenga, Rogier J. Nell, Pieter A. van der Velden, Gregorius P.M. Luyten, Robert M. Verdijk, Martine J. Jager
Published 2021-08-01